Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses.
To study the basis of cellular latency of human immunodeficiency virus (HIV), we have used a recombinant luciferase-encoding HIV (HXB-Luc) to superinfect nonproductively HIV-1-infected human leukemic cell lines. HXB-Luc contains the Photinus pyralis luciferase gene in place of the nef gene and provides a highly sensitive, simple assay for HIV infection and expression. To circumvent any superinfection block in latently infected cells, we also generated viruses pseudotyped with murine leukemia virus amphotropic envelope (HXB-Luc:ampho). The parental uninfected lines, U937 and A3.01, from which the latently infected cell lines U1 and ACH-2, respectively, were derived could be readily infected with pseudotyped or nonpseudotyped reporter viruses. However, superinfection of U1 cells with either HXB-Luc or HXB-Luc:ampho resulted in only low levels of luciferase activity. Like the endogenous provirus, HXB-Luc provirus could be efficiently activated by phorbol ester treatment of HXB-Luc:ampho-superinfected U1 cells. In contrast, superinfection of ACH-2 cells resulted in active expression of the secondarily introduced virus even in unstimulated cells and luciferase production higher than in the parental cell line A3.01. Thus, the proviral latency in U1 cells appears to result from a defect in the cellular environment (a trans effect), whereas the latency in ACH-2 is specific to the integrated provirus and is probably a cis effect due to the site of integration. These results demonstrate distinct modes of proviral latency in these two cell line models and may have implications in our understanding of the regulation and significance of cellular latency in HIV infection.
Chen
B K
BK
Rockefeller University, New York, New York 10021.
Saksela
K
K
Andino
R
R
Baltimore
D
D
D001483:Base Sequence; D015704:CD4 Antigens / Q000096:biosynthesis; D002460:Cell Line / Q000382:microbiology; D017930:Genes, Reporter; D054303:HIV Reverse Transcriptase; D015497:HIV-1 / Q000235:genetics / Q000254:growth & development*; D006801:Humans; D008156:Luciferases / Q000096:biosynthesis / Q000235:genetics; D008969:Molecular Sequence Data; D009000:Monocytes / Q000166:cytology; D010641:Phenotype; D010835:Phytohemagglutinins / Q000494:pharmacology; D011533:Proviruses / Q000235:genetics / Q000254:growth & development*; D012194:RNA-Directed DNA Polymerase / Q000378:metabolism; D011994:Recombinant Proteins / Q000096:biosynthesis; D015163:Superinfection; D013601:T-Lymphocytes / Q000166:cytology; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014158:Transcription, Genetic; D014775:Virus Activation / Q000187:drug effects; D017735:Virus Latency
D015704:CD4 Antigens; D010835:Phytohemagglutinins; D011994:Recombinant Proteins; D008156:Luciferases; D054303:HIV Reverse Transcriptase; D012194:RNA-Directed DNA Polymerase; D013755:Tetradecanoylphorbol Acetate